SMN1 and proximal spinal muscular atrophy: The authors conclude that SMA patients’ metabolism may be predominantly anaerobic, relying largely on glycolytic pathways, compared to healthy controls, and address mitochondria dysfunction and biogenesis downregulation—and the consequent NMJ and muscle impairment—to explain such abnormalities [46], which may be a downstream effect of SMN depletion.